Browsing by Subject 

Browsing by Subject "Antidepressius"

Now showing items 1-5 of 5

    • 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs 

      López-Arnau, Raúl; Camarasa, Jordi; Carbó, Marcel·lí; Nadal Gratacós, Núria; Puigseslloses, Pol; Espinosa Velasco, María; Urquizu, Edurne; Fonseca, David; Pubill, David (Frontiers in Psychiatry, 2022)
      The utility of classical drugs used to treat psychiatric disorders (e.g., antidepressants, anxiolytics) is often limited by issues of lack of efficacy, delayed onset of action or side effects. Psychoactive ...

    • CES1 and SLC6A2 genetic variants as predictors of response to methylphenidate in autism spectrum disorders 

      Hernández Hernández, Marta; Bote, Valentin; Serra-Llovich, Alexandre; Cendros, Marc; Salazar, Juliana; Mestres, Concepció; Guijarro, Silvina; Alvarez, Aida; Lamborena, Cristina; Mendez, Iria; Sánchez, Bernardo; Hervas, Amaia; Arranz, Maria J (Pharmacogenomics and personalized medicine, 2022, vol. 15, p. 951-957, 2022-11)
      Purpose Autistic spectrum disorders (ASD) children and adolescents usually present comorbidities, with 40–70% of them affected by attention deficit hyperactivity disorders (ADHD). The first option of ...

    • Pharmacogenetic influences on the response to pharmacological treatment in autism spectrum disorders 

      Hervas, Amaia; Serra-Llovich, Alexandre; Rueda, Isabel; Targa, Irene; Guijarro, Silvina; Bigorra, Aitana; Cancino, Martha; Bote, Valentin; Cárcel, María; Amasi-Hartoonian, Nare; Hernández Hernández, Marta; Arranz, Maria J (Journal of Translational Genetics and Genomics, 2021, 5:278-287, 2021-07)
      Aim: About a third of patients with autism spectrum disorder (ASD) receive pharmacological treatment for comorbid symptoms. However, 30%-50% do not respond adequately and/or present severe and long-lasting ...

    • Pharmacogenetic interventions improve the clinical outcome of treatment-resistant autistic spectrum disorder sufferers 

      Arranz, Maria J; Salazar, Juliana; Bote, Valentin; Artigas-Baleri, Alícia; Serra-Llovich, Alexandre; Triviño, Emma; Roige, Jordi; Lombardia, Carlos; Cancino, Martha; Hernández Hernández, Marta; Cendros, Marc; Duran-Tauleria, Enric; Maraver, Natalia; Hervas, Amaia (Pharmaceutics, 2022, 14 (5), 999, 2022-05)
      BACKGROUND: Autistic spectrum disorders (ASD) are severe neurodevelopmental alterations characterised by deficits in social communication and repetitive and restricted behaviours. About a third of ...

    • Trajectories of antidepressant use and 6-year change in body weight: a prospective population-based cohort study 

      Lassale, Camille; Lugon, Gabriela; Hernáez, Álvaro; Frank, Philipp; Marrugat, Jaume; Ramos, Rafel; Garre-Olmo, Josep; Elosua, Roberto (Frontiers in Psychiatry, 2024, 15: 1464898, 2024-12)
      Background: Antidepressant drug treatment may be associated with weight gain, but long-term studies are lacking. Methods: We included 3,127 adults (1,701 women) from the REGICOR study, aged 55.6 (SD ...